Antimicrobial activity of CaO nanoparticles

Journal of Biomedical Nanotechnology

Volumn 9, Issue 9, 2013, Pages 1570-1578

  Roy, Arup ^a   Gauri, Samiran S ^a   Bhattacharya, Madhusmita ^b   Bhattacharya, Jayanta ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b GITAM UNIVERSITY   (India)

Author keywords

Antimicrobial activity; Biofilm; CaO nanoparticles; Minimum inhibitory concentration (MIC); Multidrug resistant

Indexed keywords

ANTI-MICROBIAL ACTIVITY; BIOACTIVE NANOPARTICLES; GRAM-POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANTS; NARROW SIZE DISTRIBUTIONS; PHYSIO-CHEMICAL PROPERTIES; STAPHYLOCOCCUS EPIDERMIDIS;

ANTIMICROBIAL AGENTS; BIOFILMS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MICROORGANISMS; PRODUCT DEVELOPMENT; X RAY DIFFRACTION;

NANOPARTICLES;

CALCIUM OXIDE NANOPARTICLE; METAL NANOPARTICLE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA TROPICALIS; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; MICROWAVE IRRADIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPE; STAPHYLOCOCCUS EPIDERMIDIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; YEAST;

ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CALCIUM COMPOUNDS; CELL SURVIVAL; MATERIALS TESTING; NANOCAPSULES; OXIDES; PARTICLE SIZE;

EID: 84883443517     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1681     Document Type: Article

References (53)

1. E. Vanhaecke, J. P. Remon, M. Moors, F. Raes, D. D. Rudder, and A. V. Peteghem, Kinetics of pseudomonas aeruginosa adhesion to 304 and 316-L stainless steel: Role of cell surface hydrophobicity. Appl. Environ. Microbiol. 56, 788 (1990).
2. S. Cappello and S. P. P. Guglielmino, Effects of growth temperature on polystyrene adhesion of Pseudomonas aeruginosa ATCC 27853. Braz. J. Microbiol. 37, 205 (2006).
3. Z. Gao, C. H. Tseng, Z. Pei, and M. J. Blaser, Molecular analysis of human forearm superficial skin bacterial biota. Proc. Natl. Acad. Sci. USA 104, 2927 (2007).
4. G. L. Archer, Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices. Antimicrob. Agents Chemother. 14, 353 (1978).
5. J. W. Bender and W. T. Hughes, Fatal Staphylococcus epidermidis sepsis following bone marrow transplantation. Johns Hopkins Med. J. 146, 13 (1980).
6. L. E. Blouse, G. D. Lathrop, L. W. Kolonel, and R. M. Brockett, Epidemiologic features and phage types associated with nosocomial infections caused by Staphylococcus epidermidis. Zentralbl Bakteriol Parasitenk Infektionsk Hyg Abt 1 Orig Reihe A 241, 119 (1978).
7. R. P. Callaghan, S. J. Cohen, and G. T. Stewart, Septicaemia due to colonization of Spitz-Holter valves by staphylococci. Br. Med. J. 1, 860 (1961).
8. S. C. Schoenbaum, P. Gardner, and J. Shillito, Infection of cerebrospinal fluid shunts: Epidemiology, clinical manifestations and therapy. J. Infect. Dis. 131, 543 (1975).
9. W. G. Powderly, K. H. Mayer, and J. R. Perfect, Diagnosis and treatment of oropharingeal candidiasis in patients infected with HIV: A critical reassessment. AIDS Res. Hum. Retroviruses 15, 1405 (1999).
10. J. W. Rippon, Medical Mycology, 3rd edn. WB Saunders Co, Philadelphia, USA (1988).
11. D. Law, C. B. Moore, L. A. Joseph, M. G. Keaney, and D. W. Denning, High incidence of antifungal drug resistance in Candida tropicalis. Int. J. Antimicrob. Agents 7, 241 (1996).
12. J. S. Kim, E. Kuk, K. N. Yu, J. H. Kim, S. J. Park, H. J. Lee, S. H. Kim, Y. K. Park, Y. H. Park, C. Y. Hwang, Y. K. Kim, Y. S. Lee, D. H. Jeong, and M. H. Cho, Antimicrobial effects of silver nanoparticles. Nanomed. Nanotechnol. Biol. Med. 3, 95 (2007).
13. P. Wang, Nanoscale biocatalyst systems. Curr. Opinion. Biotechnol. 17, 574 (2006).
14. L. Zhang, F. X. Gu, J. M. Chan, A. Z. Wang, R. S. Langer, and O. C. Farokhzad, Nanoparticles in medicine: Therapeutic applications and developments. Clin. Pharmacol. Ther. 83, 761 (2008).
15. B. Hong, J. Kai, Y. Ren, J. Han, Z. Zou, C. H. Ahn, and K. A. Kang, Part VII-Nano-Bio Technology-30 Highly sensitive rapid, reliable, and automatic cardiovascular disease diagnosis with nanoparticle fluorescence enhancer and MEMS. Adv. Exp. Med. Biol. 614, 265 (2008).
16. C. F. Chau, S. H. Wu, and G. C. Yen, The development of regulations for food nanotechnology. Trends in Food Sci. Technol. 18, 269 (2007).
17. N. Vigneshwaran, A. A. Kathe, P. V. Varadarajan, R. P. Nachane, and R. Balasubramanya, Functional finishing of cotton fabrics using silver nanoparticles. J. Nanosci. Nanotechnol. 7, 1893 (2007).
18. J. M. Conlon, J. Kolodziejek, and N. Nowotny, Antimicrobial peptides from ranid frogs: Taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim. Biophys. Acta 1696, 1 (2004).
19. J. E. Paddle-Ledinek, Z. Nasa, and H. J. Cleland, Effect of different wound dressings on cell viability and proliferation. Plastic Reconstruct. Surg. 117, 110S (2006).
20. E. Ulkur, O. Oncul, H. Karagoz, E. Yeniz, and B. Celikoz, Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds. Burns 31, 874 (2005).
21. U. Samuel and J. P. Guggenbichler, Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int. J. Antimicrob. Agents 23, S75 (2004).
22. G. Gosheger, J. Hardes, H. Ahrens, A. Streitburger, H. Buerger, M. Erren, A. Gunsel, F. H. Kemper, W. Winkelmann, and C. von Eiff, Silver-coated megaendoprostheses in a rabbit model - an analysis of the infection rate and toxicological side effects. Biomaterials 25, 5547 (2004).
23. J. Mohsen and B. Zahra, Protein nanoparticle: A unique system as drug delivery vehicles. Afr. J. Biotechnol. 7, 4926 (2008).
24. K. Sobha, K. Surendranath, V. Meena, K. T. Jwala, N. Swetha, and K. S. M. Latha, Emerging trends in nanobiotechnology. J. Biotech. Mol. Bio. Rev. 5, 001 (2010).
25. K. A. Laura, Y. L. Delina, and J. J. A. Pedro, Comparative ecotoxicity of nanoscale TiO2, SiO2, and ZnO water suspensions. J. Water Res. 40, 3527 (2006).
26. J. Sawai, Quantitative evaluation of antibacterial activities of metallic oxide powders ZnO, MgO and CaO by conductimetric assay. J. Microb. Meth. 54, 177 (2003).
27. K. M. Reddy, F. Kevin, B. Jason, G. W. Denise, H. Cory, and P. Alex, Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. J. Appl. Phys. Lett. 90, 1 (2007).
28. J. Sawai, H. Igarashi, A. Hashimoto, T. Kokugan, and M. Shimizu, Effect of particle size and heating temperature of ceramic powders on antibacterial activity of their slurries. J. Chem. Eng. Jpn. 29, 251 (1996).
29. O. Yamamoto, Influence of particle size on the antibacterial activity of zinc oxide. Int. J. Inorg. Mater. 3, 643 (2001).
30. S. Makhluf, R. Dror, Y. Nitzan, Y. Abramovich, R. Jelinek, and A. Gedanken, Microwave-assisted synthesis of nanocrystalline MgO and its use s a bacteriocide. Adv. Funct. Mater. 15, 1708 (2005).
31. O. Yamamoto, M. Hotta, J. Sawai, T. Sasamoto, and H. Kojima, Influence of powder characteristic of ZnO on antibacterial activityeffect of specific surface area. J. Ceram. Soc. Jpn. 106, 1007 (1998).
32. J. Sawai, E. Kawada, F. Kanou, H. Igarashi, A. Hashimoto, T. Kokugan, and M. Shimizu, Detection of active oxygen generated from ceramic powders having antibacterial activity. J. Chem. Eng. Jpn. 29, 627 (1996).
33. P. K. Stoimenov, R. L. Klinger, G. L. Marchin, and K. J. Klabunde, Metal oxide nanoparticles as bactericidal agents. Langmuir 18, 6679 (2002).
34. R. Brayner, R. Ferrari-Lliou, N. Brivois, S. Djediat, M. F. Benedetti, and F. Fievet, Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett. 6, 866 (2006).
35. Z. Xiu, Q. B. Zhang, H. L. Puppala, V. L. Colvin, and P. J. J. Alvarez, Negligible particle-specific antibacterial activity of silver nanoparticles, Nano Lett. 12, 4271 (2012).
36. N. Singh, B. Manshian, G. J. Jenkins, S. M. Griffiths, P. M. Williams, T. G. Maffeis, and C. J. Wright, Nanogenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials 30, 3891 (2009).
37. J. Sawai, H. Igarashi, A. Hashimoto, T. Kokugan, and M. Shimizu, Evaluation of growth inhibitory effect of ceramics powder slurry on bacteria by conductance method. J. Chem. Eng. Jpn. 28, 288 (1995).
38. J. Sawai and T. Yoshikaw, Quantitative evaluation of antifungal activity of metallic oxide powders (MgO, CaO and ZnO) by an indirect conductimetric assay. J. Appl. Microbiol. 96, 803 (2004).
39. A. Roy and J. Bhattacharya, Microwave-assisted synthesis and characterization of CaO nanoparticles. Int. J. Nanosci. 10, 413 (2011).
40. C. Perez, M. Paul, and P. Bazerque, An antibiotic assay by the agar well diffusion method. Acta Bio. Med. Exp. 15, 113 (1990).
41. CLSI, Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. Document M100-S17 Wayne, PA (2007).
42. A. P. Wang, Y. P. Su, S. Wang, M. Q. Shen, F. Chen, M. Chen, X. Z. Ran, T. M. Chen, and J. P. Wang, Antibacterial activity and mechanism of recombinant human εdefensin 5 against clinical antibioticresistant strains, Afr. J. Microbiol. Res. 4, 626 (2010).
43. A. Giacometti, O. Cirioni, R. Ghiselli, L. Goffi, F. Mocchegiani, A. Riva, G. Scalise, and V. Saba, Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. Antimicrob. Agents Chemother. 44, 3306 (2000).
44. P. H. S. Kwakman, A. A. Velde, C. M. J. E. Vandenbroucke-Grauls, S. J. H. Deventer, and S. A. J. Zaat, Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2. Antimicrob. Agents Chemother. 50, 3977 (2006).
45. G. Ren, D. Hu, E. W. C. Cheng, M. A. Vargas-Reus, P. Reip, and R. P. Allaker, Characterisation of copper oxide nanoparticles for antimicrobial applications. Int. J. Antimicrob. Agents 33, 587 (2009).
46. J. Jain, S. Arora, J. Rajwade, M. Jyutika, P. Omray, S. Khandelwal, and M. K. Paknikar, Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol. Pharm. 6, 1388 (2009).
47. V. S. Desai and M. Kowshik, Antimicrbial activity of titanium dioxides nanopartical synthesized by sol-gel techniques. Res. J. Microbiol. 4, 97 (2009).
48. N. Jones, B. Ray, T. K. Ranjit, and A. C. Manna, Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol. Lett. 279, 71 (2008).
49. J. Sawai, H. Kojima, H. Igarashi, A. Hashimoto, S. Shoji, T. Sawaki, A. Hakoda, E. Kawada, T. Kokugan, and M. Shimizu, Antibacterial characteristics of magnesium oxide powder. World J. Microb. Biot. 16, 187 (2000).
50. J. Sawai, S. Shiga, and H. Kojima, Kinetic analysis of death of bacteria in CaO powder slurry. Int. Biodeter. Biodegr. 47, 23 (2001).
51. O. Yamamoto, T. Shimura, J. Sawai, H. Kojima and T. Sasamoto, effect of CaO doping on antibacterial activity of ZnO powders. J. Ceram. Soc. Japan 108, 156 (2000).
52. J. Sawai, Quantitative evaluation of antibactrerial activities of metallic oxide powders (MgO, CaO and ZnO) by conductimetric assay. J. Appl. Microbiol. 89, 397 (2000).
53. K. Sugiyama, T. Suzuki, and T. Satoh, Bactericidal activity of silicate-containing hydroxyapatite. J. Antibact. Antifung. Agents 23, 67 (1995).